Supporting Treatment Access and Recovery in Re-entry (STAR-R)
STAR-R
2 other identifiers
interventional
240
1 country
2
Brief Summary
This application is aimed at testing a multicomponent intervention called "Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice (MISSION-CJ) or Peer Linkage Support post-release from two jails in Massachusetts for individuals with co-occurring substance use and mental health disorders (COD), given high rates of COD among incarcerated populations. The research will examine engagement in treatment, behavioral health outcomes, mediators and moderators, an economic analysis, and facilitators and barriers of MISSION-CJ implementation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2026
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2026
CompletedFirst Posted
Study publicly available on registry
April 29, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2030
April 29, 2026
April 1, 2026
4.1 years
April 13, 2026
April 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Engagement in Treatment
Measured by total days participating in each condition using fidelity logs adapted for each treatment arm.
Measured weekly through 6-months post enrollment
Engagement in Treatment
Measured by total community provider linkages
6-months post enrollment
Engagement in Treatment
Measured by total days participating in other healthcare services. Measured using an adapted version of the Treatment Services Review (TSR)
Measured at baseline, 3, 6, 9, 12-months post enrollment
Secondary Outcomes (12)
Self-reported Substance Use
Measured at baseline, 3, 6, 9, 12-months post enrollment
Overdose Risk
Measured at baseline, 3, 6, 9, 12-months post enrollment.
Overdoses from substances
Self reported overdoses measured at baseline, 3, 6, 9, 12-months post enrollment. Surveillance data will be captured in a one time data request from the MA PHDW post-enrollment.
Mental Health Symptoms
Measured at baseline, 3, 6, 9, 12-months post enrollment
Recidivism Risk
Measured at baseline, 3, 6, 9, 12-months post enrollment
- +7 more secondary outcomes
Other Outcomes (5)
Mutual Self-Help Group Participation
Measured at baseline, 3, 6, 9, 12-months post enrollment
Mutual Self-Help Group Participation
Measured at baseline, 3, 6, 9, 12-months post enrollment
Therapeutic Alliance
Measured at 3 and 6-months post enrollment
- +2 more other outcomes
Study Arms (2)
Full MISSION-CJ
EXPERIMENTALParticipants assigned to this condition will receive full MISSION-CJ services. MISSION-CJ services include 6-months of integrated mental health and substance use treatment and treatment planning with the MISSION-CJ Case Manager (13 session curriculum) and Peer Support Specialist (11 session curriculum). Content of these sessions will be directed using the MISSION-CJ Treatment Manual and Consumer Workbooks. MISSION-CJ teams will also provide linkages and supports to treatment services within the participant's community throughout the duration of the study.
Peer Linkage Support
ACTIVE COMPARATOROur Linkage only arm delivered by a Peer Specialist will act as the comparison group to the MISSION-CJ arm. Participants randomized to the linkage only arm will receive 6-months of linkage care from a Peer Specialist. The Peer Specialist will provide informal treatment planning as well as linkages and support to community services, but will not provide integrated dual disorders treatment, nor will this arm utilize any MISSION-CJ materials or offer Peer led groups.
Interventions
MISSION-CJ is a time-limited, cross disciplinary, team-based wraparound approach that provides 6 months of psychosocial treatment combined with assertive outreach, empowering clients to access and engage in care and community services to promote recovery and address criminogenic risk. The MISSION-CJ treatment curriculum integrates 3 evidence-based practices: 1) Critical Time Intervention (CTI), a time-limited form of assertive community treatment; 2) Dual Recovery Therapy (DRT), which is integrated mental health and substance use group therapy; and 3) Peer Support (PS), offering support for people in recovery by people in recovery.
Linkage only is provided via Peer Specialists whom have lived experiences similar to that of our participants. Linkage only includes informal treatment planning and linkages and supports to needed community services.
Eligibility Criteria
You may qualify if:
- years or older;
- Proficient in reading and writing in the English language;
- Are released from one of the participating jail/s; and
- Have a current co-occurring substance use and mental health disorder, which includes both any substance use disorder (including alcohol) and mental health disorder (including depression, anxiety, trauma related disorders, bipolar, and/or schizophrenia) as documented by the participating jails.
You may not qualify if:
- Are acutely suicidal based on the CSSRS; or
- Are acutely psychotic (as this would require a higher level of care) based on SCID-5-RV.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Massachusetts, Worcesterlead
- Cornell Universitycollaborator
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (2)
Hampshire County Jail and House of Correction
Northampton, Massachusetts, 01060, United States
Worceseter County Jail and House of Correction
West Boylston, Massachusetts, 01583, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Smelson, PsyD
University of Massachusetts, Worcester
- PRINCIPAL INVESTIGATOR
Paige Shaffer, PhD
University of Massachusetts, Worcester
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 13, 2026
First Posted
April 29, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
May 31, 2030
Study Completion (Estimated)
August 31, 2030
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be available upon publication or 1-2 years after the grant end date (September 2030), until 2036 (Certificate of Confidentiality)
- Access Criteria
- Data will be shared with authorized users within the JCOIN network.
Consistent with the NIH and the JCOIN Initiative, Underlying Primary Data collected from participants in this project will be made readily available to the public through regular submissions to the Methodology and Advanced Analytics Resource Center (MAARC) and Syracuse Qualitative Data Repository for both quantitative and qualitative data collected respectively. In consultation with the University of Massachusetts Chan Medical School's institutional review board (IRB), project consent forms will include relevant information for participants to be made aware that their de-identified data will be available to other investigators as a part of the JCOIN Initiative Public Access and Data Sharing Policy.